相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Angiotensin 1-7 Ameliorates Diabetic Cardiomyopathy and Diastolic Dysfunction in db/db Mice by Reducing Lipotoxicity and Inflammation
Jun Mori et al.
CIRCULATION-HEART FAILURE (2014)
Modulation of the action of insulin by angiotensin-(1-7)
Fernando P. Dominici et al.
CLINICAL SCIENCE (2014)
Loss of NPX2 (gp91phox) prevents oxidative stress and progression to advanced heart failure
Nirmal Parajuli et al.
CLINICAL SCIENCE (2014)
Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications
Vaibhav B. Patel et al.
CLINICAL SCIENCE (2014)
Angiotensin-Converting Enzyme 2 Is a Critical Determinant of Angiotensin II-Induced Loss of Vascular Smooth Muscle Cells and Adverse Vascular Remodeling
Vaibhav B. Patel et al.
HYPERTENSION (2014)
Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats
Sergio H. S. Santos et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease
Wang Wang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Circulating Levels of Tumor Necrosis Factor-Alpha Receptor 2 Are Increased in Heart Failure with Preserved Ejection Fraction Relative to Heart Failure with Reduced Ejection Fraction: Evidence for a Divergence in Pathophysiology
Brendan N. Putko et al.
PLOS ONE (2014)
Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity
Jun Mori et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
Manuel Haschke et al.
CLINICAL PHARMACOKINETICS (2013)
Angiotensin-(1-7): beyond the cardio-renal actions
Danielle G. Passos-Silva et al.
CLINICAL SCIENCE (2013)
Angiotensin 1-7 as Means to Prevent the Metabolic Syndrome Lessons From the Fructose-Fed Rat Model
Yonit Marcus et al.
DIABETES (2013)
Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats
Jennifer Lo et al.
EXPERIMENTAL PHYSIOLOGY (2013)
Loss of Angiotensin-Converting Enzyme-2 Exacerbates Diabetic Cardiovascular Complications and Leads to Systolic and Vascular Dysfunction A Critical Role of the Angiotensin II/AT1 Receptor Axis
Vaibhav B. Patel et al.
CIRCULATION RESEARCH (2012)
Agonist-Induced Hypertrophy and Diastolic Dysfunction Are Associated With Selective Reduction in Glucose Oxidation A Metabolic Contribution to Heart Failure With Normal Ejection Fraction
Jun Mori et al.
CIRCULATION-HEART FAILURE (2012)
Role of ACE2 in diastolic and systolic heart failure
Wang Wang et al.
HEART FAILURE REVIEWS (2012)
Cardioprotective Effects Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin 1-7 in Experimental Heart Failure in Angiotensin-Converting Enzyme 2-Null Mice
Vaibhav B. Patel et al.
HYPERTENSION (2012)
Angiotensin signalling in pulmonary fibrosis
Bruce D. Uhal et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Recombinant Expression and Characterization of Human and Murine ACE2: Species-Specific Activation of the Alternative Renin-Angiotensin-System
Marko Poglitsch et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2012)
Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47phox NADPH oxidase subunit
Sreedhar Bodiga et al.
CARDIOVASCULAR RESEARCH (2011)
Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology
YanFei Qi et al.
EXPERIMENTAL PHYSIOLOGY (2011)
Prevention of Angiotensin II-Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2
JiuChang Zhong et al.
HYPERTENSION (2011)
Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kγ-dependent manner
Ahmed E. Awad et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
JiuChang Zhong et al.
CIRCULATION (2010)
Loss of PI3Kγ Enhances cAMP-Dependent MMP Remodeling of the Myocardial N-Cadherin Adhesion Complexes and Extracellular Matrix in Response to Early Biomechanical Stress
Danny Guo et al.
CIRCULATION RESEARCH (2010)
Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
Gavin Y. Oudit et al.
DIABETES (2010)
Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2 Prevention of Angiotensin II-Dependent Hypertension
Jan Wysocki et al.
HYPERTENSION (2010)
Angiotensin-(1-7) Prevents Cardiomyocyte Pathological Remodeling Through a Nitric Oxide/Guanosine 3 ',5 '-Cyclic Monophosphate-Dependent Pathway
Eneas R. M. Gomes et al.
HYPERTENSION (2010)
Simultaneous administration of Ang(1-7) or A-779 does not affect the chronic hypertensive effects of angiotensin II in normal rats
John P. Collister et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2010)
Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction
Zamaneh Kassiri et al.
CIRCULATION-HEART FAILURE (2009)
Regulation of ACE2 in cardiac myocytes and fibroblasts
Patricia E. Gallagher et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin - Efficacy of recoupling nitric oxide synthase as a therapeutic strategy
An L. Moens et al.
CIRCULATION (2008)
Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart
Chantal Mercure et al.
CIRCULATION RESEARCH (2008)
Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes
Marco F. Dias-Peixoto et al.
HYPERTENSION (2008)
Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells
Walkyria O. Sampaio et al.
HYPERTENSION (2007)
Role of oxidative stress in cardiac hypertrophy and remodeling
Eiki Takimoto et al.
HYPERTENSION (2007)
Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7)
Justin L. Grobe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways
Walkyria Oliveira Sampaio et al.
HYPERTENSION (2007)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects
M Iwata et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of Mas-knockout mice
VS Lemos et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas
RAS Santos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Nitric oxide regulation of myocardial contractility and calcium cycling - Independent impact of neuronal and endothelial nitric oxide synthases
SA Khan et al.
CIRCULATION RESEARCH (2003)
A human homolog of angiotensin-converting enzyme - Cloning and functional expression as a captopril-insensitive carboxypeptidase
SR Tipnis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
M Donoghue et al.
CIRCULATION RESEARCH (2000)